Drug
Sodium Citrate
Important: Reactions below are the flagged terms from this drug’s
FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate
disproportionality in spontaneous reporting, not causation.
Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.
| Reaction | Co-reports (a) | PRR | ROR | Signal | |
|---|---|---|---|---|---|
| 1 | Appendicitis | 230 | 431.5 | 530.3 | signal |
| 2 | Ventricular Fibrillation | 214 | 333.2 | 403.0 | signal |
| 3 | Cardiogenic Shock | 226 | 273.7 | 334.9 | signal |
| 4 | Multiple Organ Dysfunction Syndrome | 231 | 142.0 | 174.5 | signal |
| 5 | Ascites | 231 | 134.6 | 165.4 | signal |
| 6 | Incorrect Route Of Product Administration | 125 | 127.4 | 141.7 | signal |
| 7 | Bacterial Infection | 118 | 108.7 | 120.1 | signal |
| 8 | Hyperlipidaemia | 66 | 94.2 | 99.4 | signal |
| 9 | Neuralgia | 116 | 81.7 | 90.1 | signal |
| 10 | Hyponatraemia | 252 | 76.6 | 96.0 | signal |
| 11 | Ulcer | 66 | 70.7 | 74.7 | signal |
| 12 | End Stage Renal Disease | 75 | 69.5 | 74.0 | signal |
| 13 | Gout | 65 | 61.7 | 65.1 | signal |
| 14 | Caesarean Section | 40 | 58.0 | 59.9 | signal |
| 15 | Stress | 228 | 54.1 | 66.1 | signal |
| 16 | Blood Test Abnormal | 43 | 52.2 | 54.1 | signal |
| 17 | Blood Calcium Decreased | 33 | 49.9 | 51.2 | signal |
| 18 | Blood Cholesterol Increased | 128 | 46.8 | 52.1 | signal |
| 19 | Abdominal Distension | 240 | 39.3 | 48.6 | signal |
| 20 | Chronic Obstructive Pulmonary Disease | 120 | 39.2 | 43.4 | signal |
| 21 | Aspiration | 24 | 37.8 | 38.5 | signal |
| 22 | Sepsis | 241 | 36.8 | 45.5 | signal |
| 23 | General Physical Health Deterioration | 245 | 36.3 | 45.1 | signal |
| 24 | Drug Exposure During Pregnancy | 73 | 36.1 | 38.3 | signal |
| 25 | Hypercholesterolaemia | 18 | 32.0 | 32.5 | signal |
| 26 | Status Epilepticus | 21 | 31.6 | 32.1 | signal |
| 27 | Micturition Urgency | 21 | 31.6 | 32.1 | signal |
| 28 | Dry Mouth | 147 | 30.9 | 35.0 | signal |
| 29 | Full Blood Count Abnormal | 19 | 30.7 | 31.2 | signal |
| 30 | Premature Baby | 52 | 29.3 | 30.6 | signal |
| 31 | Diabetes Mellitus | 127 | 28.2 | 31.4 | signal |
| 32 | Encephalopathy | 39 | 27.1 | 28.0 | signal |
| 33 | Thrombosis | 128 | 27.0 | 30.0 | signal |
| 34 | Sleep Disorder | 111 | 27.0 | 29.6 | signal |
| 35 | Liver Function Test Increased | 32 | 25.6 | 26.2 | signal |
| 36 | Sputum Discoloured | 14 | 25.2 | 25.5 | signal |
| 37 | Intentional Product Misuse | 117 | 22.9 | 25.2 | signal |
| 38 | Swelling | 121 | 22.1 | 24.4 | signal |
| 39 | Exposure During Pregnancy | 79 | 21.6 | 23.0 | signal |
| 40 | Obstructive Airways Disorder | 14 | 21.4 | 21.6 | signal |
| 41 | Drug Intolerance | 119 | 21.1 | 23.2 | signal |
| 42 | Pulmonary Embolism | 115 | 20.5 | 22.5 | signal |
| 43 | Lower Respiratory Tract Infection | 51 | 19.2 | 19.9 | signal |
| 44 | Brain Injury | 11 | 18.7 | 18.8 | signal |
| 45 | Iron Deficiency Anaemia | 10 | 18.5 | 18.7 | signal |
| 46 | Constipation | 234 | 18.4 | 22.5 | signal |
| 47 | Abdominal Pain | 241 | 17.6 | 21.7 | signal |
| 48 | Transaminases Increased | 22 | 16.9 | 17.1 | signal |
| 49 | Bradycardia | 52 | 16.7 | 17.3 | signal |
| 50 | Blood Creatinine Increased | 63 | 16.4 | 17.2 | signal |
| 51 | Pulmonary Mass | 14 | 16.0 | 16.2 | signal |
| 52 | Pleural Effusion | 57 | 15.9 | 16.7 | signal |
| 53 | Joint Injury | 20 | 15.9 | 16.2 | signal |
| 54 | Maternal Exposure During Pregnancy | 75 | 14.5 | 15.3 | signal |
| 55 | Somnolence | 164 | 13.9 | 15.9 | signal |
| 56 | Pulmonary Fibrosis | 15 | 13.4 | 13.5 | signal |
| 57 | Anaemia | 149 | 13.3 | 15.0 | signal |
| 58 | Coronary Artery Disease | 23 | 12.8 | 13.1 | signal |
| 59 | Aspartate Aminotransferase Increased | 40 | 12.8 | 13.2 | signal |
| 60 | Renal Impairment | 63 | 12.8 | 13.4 | signal |
| 61 | Blood Lactate Dehydrogenase Increased | 12 | 12.8 | 12.9 | signal |
| 62 | Hypoxia | 26 | 12.6 | 12.9 | signal |
| 63 | Haemoptysis | 20 | 12.2 | 12.4 | signal |
| 64 | Blood Urea Increased | 12 | 12.1 | 12.2 | signal |
| 65 | Hypotonia | 7 | 11.9 | 11.9 | signal |
| 66 | Premature Delivery | 11 | 11.7 | 11.8 | signal |
| 67 | Cardiovascular Disorder | 17 | 11.3 | 11.5 | signal |
| 68 | Foetal Exposure During Pregnancy | 51 | 10.7 | 11.1 | signal |
| 69 | Pulmonary Hypertension | 13 | 10.6 | 10.7 | signal |
| 70 | Drug Hypersensitivity | 119 | 10.4 | 11.4 | signal |
| 71 | Leukocytosis | 11 | 10.4 | 10.4 | signal |
| 72 | Toxic Epidermal Necrolysis | 9 | 10.2 | 10.2 | signal |
| 73 | Musculoskeletal Stiffness | 51 | 9.9 | 10.3 | signal |
| 74 | Condition Aggravated | 174 | 9.8 | 11.3 | signal |
| 75 | Vomiting | 270 | 9.8 | 12.3 | signal |
| 76 | Hypotension | 112 | 9.5 | 10.4 | signal |
| 77 | Eyelid Oedema | 6 | 8.7 | 8.8 | signal |
| 78 | Ischaemic Stroke | 9 | 8.6 | 8.6 | signal |
| 79 | Body Temperature Decreased | 5 | 8.6 | 8.6 | signal |
| 80 | Transient Ischaemic Attack | 17 | 8.5 | 8.6 | signal |
| 81 | Ovarian Cyst | 5 | 8.5 | 8.5 | signal |
| 82 | Pemphigus | 6 | 8.2 | 8.2 | signal |
| 83 | Rotator Cuff Syndrome | 6 | 7.9 | 8.0 | signal |
| 84 | Injection Site Induration | 6 | 7.9 | 7.9 | signal |
| 85 | Dialysis | 6 | 7.2 | 7.2 | signal |
| 86 | Hyperthyroidism | 6 | 7.1 | 7.1 | signal |
| 87 | Peritonitis | 7 | 5.7 | 5.8 | signal |
| 88 | Anorexia | 4 | 5.2 | 5.2 | signal |
| 89 | Injection Site Warmth | 6 | 5.0 | 5.0 | signal |
| 90 | Neurotoxicity | 5 | 4.9 | 4.9 | signal |
| 91 | Diabetic Ketoacidosis | 5 | 3.5 | 3.6 | signal |
| 92 | Needle Issue | 5 | 3.0 | 3.0 | signal |
| 93 | Injection Site Mass | 5 | 2.3 | 2.3 | no signal |
| 94 | Incorrect Route Of Drug Administration | 4 | 1.9 | 1.9 | no signal |